National Marrow Donor Program
Minneapolis, Minnesota, United States
Social services organization in Minneapolis, Minnesota
500 N 5th St, Minneapolis, MN 55401
About National Marrow Donor Program
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
5
Fred Hutchinson Cancer Center
1
Clinical Trials at National Marrow Donor Program
During the past decade, National Marrow Donor Program conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation
2010-08-04
2024-03-01
Active, not recruiting
85
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
2015-09-24
2024-01-01
Recruiting
50
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
2015-11-19
2028-12-21
Recruiting
224
Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant
2020-11-05
2023-12-31
Active, not recruiting
548
Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
2018-09-04
2028-01-01
Recruiting
177
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
2019-04-18
2028-04-30
Suspended
91
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "National Marrow Donor Program"
#1 collaborator was "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at National Marrow Donor Program
According to Clinical.Site data, the most researched conditions in "National Marrow Donor Program" are
"Immune System Diseases" (3 trials), "Lymphoproliferative Disorders" (3 trials), "Autoimmune Lymphoproliferative" (2 trials), "Common Variable Immunodeficiency" (2 trials) and "Primary T-cell Immunodeficiency Disorders" (2 trials). Many other conditions were trialed in "National Marrow Donor Program" in a lesser frequency.
Clinical Trials Intervention Types at National Marrow Donor Program
Most popular intervention types in "National Marrow Donor Program" are "Procedure" (5 trials), "Drug" (4 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "GVHD Prophylaxis" (2 trials), "Reduced Intensity Conditioning" (2 trials), "ATL-RIC" (1 trials), "Allo BMT" (1 trials) and "Allogeneic HSC" (1 trials). Other intervention names were less common.
Clinical Trials Genders at National Marrow Donor Program
The vast majority of trials in "National Marrow Donor Program" are
6 trials for "All" genders.
Clinical Trials Status at National Marrow Donor Program
Currently, there are NaN active trials in "National Marrow Donor Program".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in National Marrow Donor Program,
1 suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in National Marrow Donor Program, 2 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".